Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Rhea-AI Summary

Syndax Pharmaceuticals (Nasdaq: SNDX) announced inducement equity awards on November 1, 2025, granting options to purchase up to 143,500 shares of common stock to four new employees under its 2023 Inducement Plan.

The options vest over four years: 25% at the one-year anniversary of the vesting commencement date and 1/48th monthly thereafter for the remaining 36 months, subject to continued service through each vesting date.

NEW YORK, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on November 1, 2025, the Company granted inducement awards to purchase up to 143,500 shares of common stock to four new employees under the Company's 2023 Inducement Plan. The stock options will vest over four years, with 25% of the underlying shares vesting on the one-year anniversary of the vesting commencement date and 1/48th of the underlying shares vesting monthly thereafter over 36 months, subject to the employee's continued service relationship with Syndax through the applicable vesting dates.

About Syndax
Syndax Pharmaceuticals is a commercial-stage biopharmaceutical company advancing innovative cancer therapies. Highlights of the Company's pipeline include Revuforj^® (revumenib), an FDA-approved menin inhibitor, and Niktimvo™ (axatilimab-csfr), an FDA-approved monoclonal antibody that blocks the colony stimulating factor 1 (CSF-1) receptor. Fueled by our commitment to reimagining cancer care, Syndax is working to unlock the full potential of its pipeline and is conducting several clinical trials across the continuum of treatment. For more information, please visit www.syndax.com or follow the Company on X and LinkedIn.

Syndax Contact

Sharon Klahre
Syndax Pharmaceuticals, Inc.
sklahre@syndax.com
Tel 781.684.9827

FAQ

What did Syndax (SNDX) announce on November 5, 2025 about new employee equity?

Syndax announced inducement awards granted November 1, 2025 to purchase up to 143,500 shares for four new employees under its 2023 Inducement Plan.

How do the Syndax SNDX inducement options vest?

Options vest over four years: 25% at the one-year anniversary and 1/48th monthly thereafter for 36 months, subject to continued service.

Which plan governs the Syndax SNDX inducement grants?

The awards were granted under Syndax's 2023 Inducement Plan.

How many employees received Syndax SNDX inducement awards?

The company granted inducement options to four new employees.

When were the Syndax SNDX inducement awards granted?

The inducement awards were granted on November 1, 2025 and announced on November 5, 2025.

Do the Syndax SNDX options require continued employment to vest?

Yes, vesting is subject to the employee's continued service through each applicable vesting date.